Foundation models are large neural networks pre-trained on extensive collections of medical images, often without detailed human labels. Instead of learning one narrowly defined diagnostic task, they are designed to produce numerical descriptions, known as feature embeddings, that can later be reused for many applications. In principle, this approach could reduce the enormous amount of labeled data required to train a medical AI system. A hospital might take a frozen, pre-trained model, extract features from its CT scans, and add a relatively simple classifier to recognize disease. But the quality of those reusable representations depends on what the model learned during pre-training and how effectively the information is converted into a prediction for an entire organ.

The researchers from Radboudumc in the Netherlands examined that process using more than 2,000 abdominal CT scans from the AMOS-MM dataset, paired with organ-level abnormality labels generated by the LEAVS system. LEAVS uses a large language model to extract findings from radiology reports, and its abnormality-type extraction has an average F1 score of 0.89 against human annotations. The investigators excluded 200 scans from model development and used them as a human-annotated test set. They assessed the spleen, gallbladder, large bowel, left kidney, right kidney and liver, while stomach, pancreas and small bowel were removed from the main analysis because severe class imbalance made reliable comparisons difficult.

For every scan, the team first used TotalSegmentator, an automated anatomical-segmentation system, to locate each organ. The organ was then enclosed in a three-dimensional bounding box, which was divided into overlapping patches. The foundation models converted these local patches into feature vectors—lists of numbers encoding patterns such as texture, shape and possibly disease-related visual signals. Those patch-level vectors had to be assembled into one organ-level representation before a classifier could determine whether the organ was abnormal. The researchers compared simple statistical operations, including mean, median, maximum and standard deviation pooling, with a combined mean-and-standard-deviation representation. They also tested attention-based multiple instance learning, in which the system learns to assign different importance to different patches, as well as a hierarchical global transformer used by one of the models.

The five principal foundation models represented different philosophies of medical AI. Some were trained on three-dimensional CT volumes, allowing them to learn relationships between adjacent slices and volumetric structures. Others were based on two-dimensional images or trained across multiple imaging modalities. Their pre-training objectives also varied, including self-distillation, contrastive learning and alignment between images and radiology reports. The models included SPECTRE, TAP-CT, CT-FM, UMedPT and Curia, with Merlin included as a reference because its large input window can contain an entire organ without the need for patch aggregation. To keep the comparison focused, the investigators trained linear classifiers and two increasingly expressive multilayer perceptrons on the resulting embeddings rather than fine-tuning the foundation models themselves.

SPECTRE produced the strongest overall performance, achieving an area under the receiver operating characteristic curve, or AUC, of 0.714 when mean pooling was used. AUC measures how well a system ranks abnormal cases above normal ones; a value of 0.5 corresponds to random guessing, while 1.0 represents perfect separation. SPECTRE significantly outperformed its version without vision-language alignment, which achieved an AUC of 0.625, and TAP-CT, which reached 0.605. CT-FM, Merlin and UMedPT occupied a middle range, while Curia performed worst, with an AUC of 0.468—slightly below random performance in this frozen feature-extraction setting. Across the comparison, three-dimensional CT-native systems generally outperformed models trained primarily on two-dimensional or multimodal data, although the authors emphasize that architecture, training data and pre-training objectives were intertwined and could not be isolated completely.

The most surprising finding was that increasingly elaborate ways of combining patches did not deliver a meaningful advantage. None of the tested aggregation strategies significantly outperformed simple mean pooling. The best alternative improved AUC by only 0.008 compared with the mean, with a 95 percent confidence interval ranging from −0.002 to 0.022. The same pattern held for focal abnormalities. Attention-based multiple instance learning did sometimes distribute its weights unevenly across patches, suggesting that the model was not always treating every region identically, but those learned preferences did not translate into better generalization on unseen scans. In some models, attention weights were nearly uniform, effectively behaving like mean pooling. SPECTRE’s hierarchical global transformer also failed to improve performance, producing a difference of −0.033 relative to mean aggregation, with uncertainty that included no difference.

Disease location and scale proved more consequential than the aggregation algorithm. When the researchers separated diffuse from focal abnormalities, only the liver and gallbladder had enough examples of each type for a reliable analysis. Among models that performed better than chance, every one classified diffuse abnormalities more accurately than focal abnormalities. The largest difference in AUC was 0.108, with a 95 percent confidence interval of 0.080 to 0.135. The researchers then gave the downstream classifier more power by replacing the linear probe with multilayer perceptrons containing one or two hidden layers. That additional capacity did not improve focal-abnormality performance, indicating that the limitation was probably not simply an overly weak classifier. In illustrative liver cases, models confidently recognized diffuse changes consistent with cirrhosis, were less certain about a lesion measuring approximately 48 by 40 millimeters, and often assigned low abnormality probabilities to a lesion of about 13 by 11 millimeters.

The technical explanation may lie in what the models are rewarded for learning during pre-training. Radiology reports commonly describe a scan or an organ in global terms, but they do not always specify the exact coordinates, size or boundaries of every abnormality. A model trained to align an entire CT examination with its report may therefore learn that a liver has a generally abnormal appearance without learning which small cluster of voxels contains the lesion. In a large organ, a focal abnormality may occupy only a tiny fraction of the total volume. If the representation averages information across many patches, the signal from that lesion can be diluted by surrounding normal tissue. Attention mechanisms can theoretically counteract this dilution by focusing on informative regions, but they cannot recover spatially discriminative information that the foundation model never encoded in its patch embeddings.

The study also found no statistically significant evidence that overlap between pre-training and evaluation scans explained SPECTRE’s advantage. SPECTRE and UMedPT had been trained partly on AMOS22 data, which overlaps with about 29 percent of the scans in the study, including some test cases. After removing those overlapping scans, SPECTRE’s performance changed by 0.022, with a confidence interval from −0.005 to 0.062, while UMedPT changed by −0.004. Neither difference was statistically significant. Nevertheless, the investigators caution that removing identical scans cannot eliminate every possible source of dataset contamination: institutions, scanners, patient populations and acquisition protocols may still overlap. The findings should also not be interpreted as clinical validation. The evaluation used one abdominal CT dataset, report-derived labels and frozen encoders, not prospective patients or fully fine-tuned diagnostic systems.

The implications are both practical and urgent. For developers using foundation models as fixed feature extractors, choosing a strong encoder may be more valuable than adding a complex aggregation module. Mean pooling, despite its simplicity, provides a competitive baseline and is easier to implement, interpret and test. But the results also expose a potentially dangerous blind spot for systems intended to support oncology, where small, localized lesions can be more clinically consequential than diffuse organ changes. Future models may need pre-training objectives that explicitly preserve spatial detail, such as lesion-focused contrastive learning, anatomically informed masking or synthetic insertion of focal lesions. Spatially grounded supervision could teach a network not only that an abnormality exists but where it is located, although such approaches may require more annotation and sacrifice some scalability. Until these strategies are tested across independent datasets and with fine-tuning, a high overall score from a medical foundation model should not be taken as evidence that it can reliably detect the smallest and most important abnormalities.

The model is built around a central idea that has already transformed language and image-based artificial intelligence: instead of training a separate algorithm for every medical question, researchers can first train a large general-purpose model to recognize patterns in complex data. That model can then be adapted to specific tasks, such as identifying people at elevated risk of disease or predicting outcomes after a clinical event. In the sleep setting, the raw material may include physiological signals recorded during overnight monitoring, including electrical activity from the brain, heart-related measurements, breathing patterns and muscle activity.

Traditional sleep analysis often depends on manually defined measurements. Specialists or automated systems divide a night into sleep stages, calculate features such as oxygen desaturation or heart-rate variability, and then use those features to assess sleep disorders. Although this approach is clinically useful, it can discard subtle information contained in the original signals. A foundation model attempts to preserve more of that detail by learning representations directly from time-varying physiological data. In technical terms, it converts long and complicated recordings into numerical representations that summarize patterns across multiple biological systems.

This strategy could be particularly important because sleep is closely linked to conditions that appear far beyond the sleep clinic. Repeated breathing interruptions, unstable oxygen levels, altered autonomic activity and abnormal sleep architecture have all been associated with cardiometabolic disease, neurological disorders and premature mortality. Yet many of these relationships are difficult to capture using a single measurement. An artificial intelligence system that can examine the full overnight physiological landscape may detect combinations of weak signals that would be difficult for conventional statistical models to recognize.

The reported model is intended to support sleep-based risk stratification, meaning that it can help separate individuals into groups with different expected levels of clinical risk. Rather than treating a sleep recording as a simple test for one disorder, the framework aims to extract information relevant to several possible outcomes. This broader approach reflects the concept of sleep as a digital biomarker: a non-invasive window into the function of multiple organ systems, collected while a person is at rest and without requiring additional daytime procedures.

Foundation models also offer a potential answer to one of medicine’s most persistent data problems. Clinical datasets are often fragmented, with different hospitals using different sensors, recording formats and diagnostic standards. Models trained for only one task or one institution may perform well in development but weaken when applied elsewhere. A more general pretraining stage can help an algorithm learn robust physiological patterns before it is fine-tuned on a narrower clinical question. The authors’ work therefore addresses not only prediction, but also the possibility of building reusable artificial intelligence infrastructure for sleep medicine.

The technical challenge is considerable. Sleep recordings are long, noisy and highly individual. Body movement can distort signals, sensors may fail, and the same physiological event can have different meanings depending on a person’s age, medical history and medication use. A useful model must learn temporal relationships across several scales, from rapid changes in breathing or electrical activity to broader transitions between sleep stages. It must also avoid confusing demographic or technical artifacts with genuine biological risk. These issues make external validation, calibration and careful assessment of fairness essential before clinical deployment.

If such systems eventually prove reliable in routine care, their impact could extend beyond specialist sleep laboratories. Sleep data might help clinicians identify people who need more intensive evaluation, prioritize follow-up, or monitor how risk changes over time. It could also support research by providing a standardized way to compare sleep-derived biological signatures across diseases. However, a prediction is not the same as a diagnosis, and an elevated risk score would require clinical interpretation rather than automatic treatment. The most valuable role for the technology may be to reveal patterns that prompt earlier, more targeted medical attention.

The study arrives as artificial intelligence is moving from narrowly programmed medical tools toward models designed to learn general representations of biology. Its significance lies in treating sleep not as an isolated nighttime behavior, but as a rich physiological record with information about future health. The work does not eliminate the need for clinicians, high-quality measurements or prospective trials. Instead, it points toward a future in which one overnight recording could provide a more comprehensive view of an individual’s biological resilience and vulnerability, potentially making sleep a central component of preventive medicine.

Subject of Research: Sleep-based artificial intelligence, foundation models, health-risk stratification and clinical outcome prediction

Article Title: A foundation model for sleep-based risk stratification and clinical outcomes

Article References: Bilal, E., Araujo, M.L.D., Beck, K.L. et al. A foundation model for sleep-based risk stratification and clinical outcomes. Nature Communications 17, 7603 (2026). https://doi.org/10.1038/s41467-026-75326-9

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41467-026-75326-9

Keywords: Sleep science, artificial intelligence, foundation model, machine learning, clinical outcomes, risk stratification, digital biomarkers, physiological signals, preventive medicine

The research team, led by Lin, S., Li, Z., and Wu, Q., among others, developed the model by capitalizing on the wealth of ECG recordings accumulated across diverse populations. By employing self-supervised learning—a method where the algorithm generates its own labels by predicting parts of the input data—the model learns robust and transferable representations without the costly requirement of manual annotation. This aspect is revolutionary for medical AI, where access to large, fully labeled datasets is often a bottleneck due to the need for expert clinicians and the intricacies of clinical data. Consequently, the model’s ability to generalize across datasets and patient cohorts may set a new standard for diagnostic tools in cardiology.

One of the most significant breakthroughs of this model is its capacity to enhance the prediction accuracy for a broad array of cardiovascular diseases, including arrhythmias, coronary artery disease, and heart failure. By distilling essential features from raw ECG waveforms, the model identifies subtle deviations invisible to the naked eye or conventional algorithms. This capability not only improves early detection rates but also opens avenues for personalized medicine by stratifying risk with finer granularity. Such stratification is crucial given the heterogeneity of cardiovascular diseases, where timely interventions can drastically alter the course of patient outcomes.

Beyond clinical diagnostics, the researchers demonstrated that the foundation model aids in uncovering genetic factors associated with cardiovascular conditions. The interplay between genetics and electrophysiological phenotypes remains a challenging frontier, and this model offers a powerful tool to bridge this gap. By integrating genomic data with ECG-derived features, the model identifies novel genetic variants linked to disease susceptibility and progression. This integrative approach could accelerate the identification of therapeutic targets and inform genetic counseling, ultimately contributing to precision cardiology.

Technically, the architecture of the foundation model leverages transformer-based neural networks, a state-of-the-art framework originally developed for natural language processing tasks but increasingly applied to biological signals. Transformers’ ability to capture long-range dependencies within time series ECG data facilitates a comprehensive understanding of cardiac electrical activity. The model’s design incorporates multiple layers of self-attention mechanisms, enabling it to focus adaptively on critical features across different temporal segments. This results in representations that are both rich and interpretable, providing a window into the model’s decision-making process.

The training protocol involved an extensive dataset of millions of ECG recordings sourced from global biobanks and clinical repositories, representing diverse demographic and clinical backgrounds. This diversity ensures that the model remains robust and unbiased when deployed across different healthcare settings. Additionally, the dataset encompassed a broad spectrum of ECG leads, allowing the model to comprehend spatial electrical variations within the heart. The training was carried out on high-performance computational clusters using optimized algorithms to handle the sheer volume and complexity of the data, underscoring the importance of interdisciplinary collaboration between machine learning experts and cardiologists.

Validation of the model showcased impressive performance metrics, surpassing traditional supervised models in both accuracy and generalizability. The evaluation spanned multiple independent cohorts, including high-risk populations, where the model adeptly identified early signs of cardiac dysfunction. Importantly, the model maintained high sensitivity and specificity, minimizing false positives and negatives, which is critical in clinical decision-making. This rigorous validation framework fosters confidence in the model’s applicability for real-world settings and its potential integration into existing clinical workflows.

Moreover, the model offers interpretability features, allowing clinicians to visualize which segments and morphological aspects of the ECG waveform contributed most to predictions. This transparency addresses the often-cited “black box” problem in AI, facilitating trust and adoption by healthcare professionals. Such interpretability also enables hypothesis generation, whereby unexpected predictive features may direct future clinical investigations and enhance our understanding of cardiac electrophysiology.

Another transformative aspect of this foundation model is its adaptability to downstream tasks through fine-tuning. Once pre-trained on massive unlabeled ECG data, it can be efficiently customized for specific clinical applications, such as predicting atrial fibrillation onset or stratifying sudden cardiac death risk. This transfer learning capability dramatically reduces the need for large labeled datasets in each niche application, accelerating development timelines and reducing costs. The modularity of the approach suggests the potential for widespread dissemination across diverse cardiovascular domains.

The research also highlights the model’s implications beyond individual patient care, extending into population health management and epidemiology. By analyzing ECG data at scale, health systems could monitor cardiovascular risk trends dynamically, identify high-risk groups, and evaluate the effectiveness of preventive interventions. These population-level insights promise more proactive and data-driven public health strategies aimed at curbing the global burden of cardiovascular diseases, which remain the leading cause of mortality worldwide.

Beyond cardiovascular applications, the foundational principles behind this self-supervised ECG model herald a broader paradigm shift in biomedical AI. The notion of building large-scale, generalizable foundation models, akin to those in natural language processing and computer vision, opens possibilities for diverse physiological signals such as electroencephalograms (EEGs), electromyograms (EMGs), and beyond. Such models could standardize feature extraction, democratize access to advanced analytics, and catalyze innovations in diagnostics and therapeutics across specialties.

However, the researchers acknowledge ethical and practical challenges preceding widespread clinical adoption. Ensuring patient data privacy, addressing potential biases, and validating regulatory standards are paramount. Collaborative frameworks involving clinicians, data scientists, ethicists, and policymakers will be essential to translate these sophisticated AI tools into equitable and safe healthcare solutions. Moreover, sustained efforts in education and training will be needed to empower clinicians to effectively harness these novel technologies.

Looking forward, the team plans to expand their model to incorporate multimodal data sources, integrating ECG with imaging, clinical records, and wearable device streams. Such comprehensive models promise holistic cardiovascular profiling, capturing structural, functional, and electrophysiological dimensions simultaneously. This integrative approach could ultimately usher in truly personalized and anticipatory cardiology, transforming prevention, diagnosis, and treatment paradigms.

In summary, this self-supervised ECG foundation model represents a milestone in the fusion of artificial intelligence and cardiovascular medicine. By unlocking latent information within routine ECG signals and linking them with genetic insights, it paves the way for earlier, more accurate disease prediction and a profound understanding of disease mechanisms. As this technology matures, it holds the potential to substantially improve patient outcomes, reduce healthcare costs, and advance the frontiers of cardiovascular science.

Subject of Research:

Article Title:

Article References:
Lin, S., Li, Z., Wu, Q. et al. A self-supervised electrocardiogram foundation model for empowering cardiovascular disease prediction and genetic factor discovery. Nat Commun (2026). https://doi.org/10.1038/s41467-026-72436-2

Image Credits: AI Generated

Merlin represents a new paradigm in artificial intelligence within medical imaging—unifying vast, unlabeled datasets through the application of foundation models. Unlike conventional approaches restricted to narrowly defined tasks, Merlin’s training employed an extensive and unique dataset encompassing more than 15,000 clinically annotated 3D abdominal CT scans paired with corresponding radiology reports and nearly one million diagnosis codes. This expansive trove emanates from the Stanford University School of Medicine, forming the most comprehensive abdominal CT database assembled to date, thus enabling Merlin to learn sophisticated relationships between visual imaging and textual medical knowledge.

The strength of Merlin stems from its innovative architecture which facilitates the fusion of complex three-dimensional scan data with the semantic richness of natural language reports. This integration empowers the model to undertake over 750 distinct tasks, ranging from elementary anatomical delineation to the intricate prediction of disease development years before clinical manifestation. By harnessing multi-modal inputs during training, Merlin effectively bridges the gap between raw imaging data and diagnostic interpretation, a task that conventionally requires expert human radiologists supported by multiple rounds of clinical testing and evaluation.

Merlin’s performance was rigorously evaluated by challenging the model with over 50,000 previously unseen abdominal CT scans sourced from four independent hospitals. The model exhibited extraordinary proficiency in correlating imaging findings with human-generated diagnostic labels and conclusions. For example, Merlin’s ability to predict relevant ICD codes associated with individual scans surpassed other contemporary AI tools, achieving greater than 81% accuracy across a broad suite of diagnostic labels and peaking at 90% accuracy within certain disease subsets. These results underscore Merlin’s potential as a reliable clinical assistant in routine radiological workflows.

Beyond retrospective diagnostic tasks, Merlin demonstrates a remarkable capacity for forecasting future disease trajectories. In predictive tests focusing on chronic diseases—such as diabetes, osteoporosis, and cardiovascular illnesses—the model effectively identified individuals at elevated risk years before the clinical onset of disease based solely on their abdominal CT scans. Specifically, Merlin’s predictive accuracy reached 75%, outperforming comparator models operating at 68%. This ability suggests the presence of subtle imaging biomarkers, heretofore unnoticed by human experts, which Merlin is uniquely equipped to detect and interpret.

A particularly compelling facet of Merlin’s versatility is its adaptability to imaging domains outside its initial training data. Despite being exclusively trained on abdominal CT scans, Merlin was tasked with interpreting chest CT images—a domain with divergent anatomical and pathological features. Impressively, Merlin matched or exceeded the diagnostic performance of models specifically trained on chest imaging data, further evidencing its generalizability and the power of foundational learning approaches within medical AI.

Although Merlin is a “jack-of-all-trades,” competing with specialized models tailored for individual diagnostic tasks, it consistently matched or outperformed these experts. This comprehensive capability cultivates excitement for integrating Merlin into clinical practice not merely as a supplemental tool but potentially as a primary diagnostic aid. Its ability to reduce reliance on scarce radiological expertise may alleviate burgeoning physician shortages while streamlining diagnostic workflows, thereby accelerating patient care and treatment initiation.

Despite these advances, some tasks such as drafting complete radiology reports from scratch remain challenging and require further refinement of Merlin’s learning algorithms and fine-tuning with more targeted datasets. The research team advocates for continuous model refinement through domain-specific customization, encouraging practitioners to augment Merlin with local clinical data to enhance performance tailored to specialized clinical environments or demographic variations.

At its core, Merlin epitomizes a leap forward in multi-modal artificial intelligence research—combining the raw spatial complexity of volumetric CT data with the semantic depth inherent in diagnostic narratives. This confluence enables the model to understand and predict disease with a degree of nuance unattainable by previous generation AI systems. The synergy between data scale, model design, and diverse task demands positions Merlin as a foundational tool upon which future medical imaging innovations can be built.

This research, supported by several NIH institutes under multiple grants, also marks a pivotal collaboration between AI researchers and clinical scientists. It illuminates the potential for AI-driven tools not only to automate routine image analysis but also to reveal new medical insights, transforming radiology from a solely human-driven discipline into a synergistic human-machine partnership.

As the community begins to adopt and build upon Merlin, the implications span beyond immediate clinical applications. The model’s capacity to identify subtle patterns invisible to human eyes fuels optimism about discovering novel imaging biomarkers. Such biomarkers could inaugurate new frontiers in understanding disease pathophysiology, risk stratification, and personalized medicine, reshaping the landscape of preventative healthcare.

Ultimately, Merlin heralds a future where the integration of advanced AI models streamlines clinical decision-making, enhances diagnostic accuracy, and expands the role of medical imaging in health management. As senior author Akshay Chaudhari from Stanford University aptly noted, this foundational AI model is poised to be a robust backbone for the broader medical community, and from this platform, the potential applications are bound only by the limits of innovation itself.

Subject of Research: Medical imaging and machine learning application in computed tomography (CT) scan analysis.

Article Title: Merlin: A Computed Tomography Vision Language Foundation Model and Dataset

News Publication Date: 4-Mar-2026

Web References:
https://www.nature.com/articles/s41586-026-10181-8

References:
Louis Blankemeier, Ashwin Kumar, et al. Merlin: A Computed Tomography Vision Language Foundation Model and Dataset. Nature. 2026 DOI: 10.1038/s41586-026-10181-8.

Keywords

Health and medicine, Artificial intelligence, Medical imaging, Clinical imaging

Foundation models represent a paradigm shift, as they can be trained on vast amounts of unlabeled data and subsequently fine-tuned with smaller, labeled datasets for a variety of clinical tasks. By leveraging large-scale, multimodal datasets, these models possess the ability to generalize across various applications, making them particularly valuable in oncology, where diverse data sources—such as histopathological images, clinical reports, and genomic information—must be integrated for comprehensive patient assessments.

Pathological foundation models harness the power of self-supervised learning, a technique that allows them to learn from vast datasets without the need for human annotation. This capability significantly reduces the time and costs associated with model training, which is often a bottleneck in traditional approaches. As reported by leading researchers—Dr. S.Kevin Zhou, Dr. Rui Yan, and Dr. Fei Ren, along with their collaborators—these models pave the way for novel applications in precision oncology. Their research highlights how foundation models enhance diagnostic accuracy and efficiency while simultaneously improving patient care and reducing healthcare costs.

One of the most exciting aspects of foundation models is their ability to perform multiple tasks with minimal annotated data. Current research categorizes these models into three primary types: pathology image foundation models, pathology image-text foundation models, and pathology image-gene foundation models. Each category represents a unique intersection of imaging, textual interpretation, and integrative data analysis, promising immense opportunities for the advancement of precision medicine.

Pathology image foundation models focus on extracting critical features from whole slide images (WSIs) and have demonstrated capabilities in tasks like cancer classification, tumor grading, and biomarker prediction. Notable representatives include GigaPath, UNI, and Virchow, each proving to outperform traditional models across various cancer types and providing healthcare professionals with more reliable diagnostic tools. These models streamline the diagnostic workflow, facilitate timely clinical decision-making, and ultimately contribute to improved patient outcomes.

In addition, pathology image-text foundation models incorporate natural language processing, enabling the integration of visual data with textual information from pathology reports. This cross-modal capability supports tasks such as diagnostic report generation and educational resources for pathologists. Models like PLIP, CONCH, and PathChat exemplify this approach by applying zero-shot learning—effectively allowing models to tackle previously unseen cases, thereby enhancing the digital pathology landscape. By grasping the semantics of images through natural language annotations, these models support a more intuitive understanding of diagnostic processes.

Furthermore, the synergy between pathology images and genomic data is exemplified by pathology image-gene foundation models. By aligning visual and omics data, models like mSTAR, GiMP, and TANGLE have substantially improved the precision of tumor classification and treatment response predictions. This integration promises to unveil insights into cancer heterogeneity and molecular mechanisms that can inform targeted therapies, thereby refining the overall treatment trajectory for patients.

Despite their impressive capabilities, pathology foundation models face crucial challenges regarding clinical implementation. A significant issue is the lack of extensive validation across diverse, multi-center datasets, which raises concerns about the models’ reliability and robustness in real-world settings. Moreover, the “black-box” nature of these models can inhibit clinical acceptance, as healthcare professionals seek transparent and interpretable insights to guide their decision-making processes. Strengthening the interpretability of model outputs and elucidating the underlying biological mechanisms have thus emerged as critical research focal points.

In the realm of multi-modal integration, researchers are actively seeking solutions to address challenges such as data redundancy and conflicts encountered between different modalities. This presents an opportunity for future research to delve into long-sequence modeling and high-dimensional feature fusion, while ensuring that ethical guidelines govern the development of AI applications in healthcare. The vision for foundation models extends beyond mere utility; they are setting the groundwork for the evolution of intelligent, automated, and personalized decision-support systems in pathology.

The promise of foundation models lies not only in reshaping computational pathology but also in the broader context of precision oncology and life sciences research. With the continuing advancements in these models, there is immense potential for enhanced diagnostic accuracy, improved patient experiences, and reduced costs. As healthcare systems increasingly seek adaptable and intelligent solutions, the ongoing evolution of foundation models stands poised to catalyze transformative changes in how cancer is diagnosed and managed.

In conclusion, the significance of foundation models in computational pathology cannot be overstated. They are pioneering a shift in the paradigms that have traditionally governed pathology, introducing pathways to more efficient, accurate, and adaptable methodologies. As research deepens and these models undergo further refinement, their convergence with clinical practice heralds a new era of personalized healthcare, all the while holding the promise of bringing profound improvements to patient care in precision oncology.

Subject of Research: Emerging Paradigms in Computational Pathology
Article Title: Computational pathology in precision oncology: Evolution from task-specific models to foundation models
News Publication Date: 25-Sep-2025
Web References: Chinese Medical Journal
References: DOI: 10.1097/CM9.0000000000003790
Image Credits: Chinese Medical Journal

Keywords

• Oncology
• Cancer
• Biomedical Engineering
• Artificial Intelligence
• Health and Medicine